Ed Rayner

AMP Capital Investors Ltd. (AMPCI) is the wholly-owned investment management subsidiary of AMP Capital Holdings Ltd., ultimately held by financial group AMP Ltd. (ASX: AMP) in Australia. Founded in 1849 as the non-profit Australian Mutual Provident Society, the group is an Australian superannuation provider and asset manager. The firm is headquartered in Sydney with additional offices in New Zealand, Dubai, China, Hong Kong, India, Ireland, Japan, Luxembourg, UK and the US. They were one of the first to invest in infrastructure when they participated in the financing of the Sydney Harbour Tunnel in 1988. AMPCI is a socially responsible investor which manages a range of unlisted and listed infrastructure investments in Asia, Europe, North America, Australia and New Zealand as well as life insurance, institutional and mutual funds for the AMP group.

AllianceBernstein (Australia) Ltd. (ABAL) is the Australian subsidiary of AllianceBernstein Holdings (Cayman) Ltd., ultimately owned by AXA Equitable Holdings, Inc. (NYSE: EQH) in the US. The firm is headquartered in Sydney with additional office in Melbourne. They provide diversified investment management services worldwide to institutional, high-net worth individuals and retail investors.

Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation.